150 related articles for article (PubMed ID: 7370988)
1. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide.
Scheving LE; Burns ER; Pauly JE; Halberg F
Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988
[No Abstract] [Full Text] [Related]
2. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
Avery TL; Roberts D
Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
Roberts D; Hilliard SL
Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
[No Abstract] [Full Text] [Related]
4. Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-beta-D-arabinofuranosylcytosine.
Scheving LE; Burns ER; Pauly JE; Halberg F; Haus E
Cancer Res; 1977 Oct; 37(10):3648-55. PubMed ID: 908013
[TBL] [Abstract][Full Text] [Related]
5. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
Burns ER; Scheving LE
Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
[No Abstract] [Full Text] [Related]
6. Chronochemotherapy: L 1210 leukemia and beyond.
Halberg F; Nelson W; Cornélissen G; Haus E; Scheving LE; Good RA
Chronobiologia; 1979; 6(3):203-11. PubMed ID: 520097
[TBL] [Abstract][Full Text] [Related]
7. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
Fiszer-Maliszewska L; Mordarski M
Arch Immunol Ther Exp (Warsz); 1981; 29(6):703-10. PubMed ID: 7349092
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
Valeriote F; Vietti T; Coulter D
J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
Avery TL; Cruze PG
Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
[No Abstract] [Full Text] [Related]
11. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
Grossie VB; Rosenblum MG; Loo TL
Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
[TBL] [Abstract][Full Text] [Related]
12. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
Rose WC; Trader MW; Laster WR; Schabel FM
Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
[No Abstract] [Full Text] [Related]
13. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.
Scheving LE; Burns ER; Halberg F; Pauly JE
Chronobiologia; 1980; 7(1):33-40. PubMed ID: 7192203
[TBL] [Abstract][Full Text] [Related]
14. Adriamycin/cyclophosphamide combination chemotherapy: the importance of drug scheduling.
Mulder JH; van Putten LM
Eur J Cancer (1965); 1979 Dec; 15(12):1503-9. PubMed ID: 294960
[No Abstract] [Full Text] [Related]
15. Single versus combination chemotherapy of L1210 leukemia.
Koza I; Balázová E; Ujházy V
Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
[TBL] [Abstract][Full Text] [Related]
16. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy: arriving at optimal treatment levels by incorporating side effect constraints.
Wampler GL; Carter WH; Williams VR
Cancer Treat Rep; 1978 Mar; 62(3):333-40. PubMed ID: 647694
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
Stoychkov JN; Milushev AS; Todorov DK
Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.
Gale GR; Atkins LM; Meischen SJ; Schwartz P
Cancer Treat Rep; 1979 Mar; 63(3):449-56. PubMed ID: 427825
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and ricin, a strongly synergistic combination in mouse leukemia.
Fodstad O; Pihl A
Cancer Treat Rep; 1980; 64(12):1375-8. PubMed ID: 7471125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
